Hind Limb Ischemia-Reperfusion in the Leptin Receptor Deficient (db/db) Mouse

Journal of Surgical Research

Volumn 139, Issue 1, 2007, Pages 97-105

  Entabi, Fateh ^a   Albadawi, Hassan ^a   Stone, David H ^a   Sroufe, Rameses ^a   Conrad, Mark F ^a   Watkins, Michael T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cytokines; diabetes; inflammation; reperfusion injury

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; LEPTIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL VIABILITY; CONTROLLED STUDY; FEMALE; HISTOLOGY; LASER; LEG ISCHEMIA; MITOCHONDRION; MOUSE; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; TISSUE INJURY; TISSUE PERFUSION; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; CHEMOKINES, CXC; DIABETES MELLITUS, TYPE 2; FEMALE; HINDLIMB; INTERLEUKIN-6; MICE; MUSCLE, SKELETAL; RECEPTORS, CELL SURFACE; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33947603025     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.08.008     Document Type: Article

References (42)

1. Akbari C., and Logerfro F. Diabetes and peripheral vascular disease. J Vasc Surg 30 (1999) 373
2. Ruderman N., and Haudenschild C.C. Diabetes as an atherogenic factor. Prog Cardiovasc Dis 26 (1984) 373
3. Nathan D. Longterm complications of diabetes mellitus. N Engl J Med 328 (1993) 1676
4. Melliere D., Berrahal P., Allaire E., et al. Influence of diabetes on revascularization procedures of the aorta and lower limb arteries: Early results. Eur J Vasc Endovasc Surg 17 (1999) 438
5. AhChong A.K., Chiu K.M., Wong M.W., et al. Diabetes and the outcome of infrainguinal bypass for critical limb ischaemia. ANZ J Surg 74 (2004) 129
6. Virkkunen J., Heikkinen M., Lepantalo M., et al. Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. J Vasc Surg 40 (2004) 761
7. Bodary P.F., Westrick R.J., Wickenheiser K.J., et al. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA 287 (2002) 1706
8. Maachi M., Pieroni L., Bruckert E., et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 28 (2004) 993
9. Chua Jr. S.C., Liu S.M., Li Q., et al. Transgenic complementation of leptin receptor deficiency. II. Increased leptin receptor transgene dose effects on obesity/diabetes and fertility/lactation in lepr-db/db mice. Am J Physiol Endocrinol Metab 286 (2004) E384
10. Ring B.D., Scully S., Davis C.R., et al. Systemically and topically administered leptin both accelerate wound healing in diabetic ob/ob mice. Endocrinology 141 (2000) 446
11. Bonheur J.A., Albadawi H., Patton G.M., et al. A noninvasive murine model of hind limb ischemia-reperfusion injury. J Surg Res 116 (2004) 55
12. Chua Jr. S.C., White D.W., Wu-Peng X.S., et al. Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr). Diabetes 45 (1996) 1141
13. Belkin M., Brown R.D., Wright J.G., et al. A new quantitative spectrophotometric assay of ischemia-reperfusion injury in skeletal muscle. Am J Surg 156 (1988) 83
14. Pakala S.V., Chivetta M., Kelly C.B., et al. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med 189 (1999) 1053
15. Hearse D.J., Stewart D.A., and Chain E.B. Diabetes and the survival and recovery of the anoxic myocardium. J Mol Cell Cardiol 7 (1975) 397
16. Feuvray D., Idell-Wenger J.A., and Neely J.R. Effects of ischemia on rat myocardial function and metabolism in diabetes. Circ Res 44 (1979) 322
17. Vogel W.M., and Apstein C.S. Effects of alloxan-induced diabetes on ischemia-reperfusion injury in rabbit hearts. Circ Res 62 (1988) 975
18. Tani M., and Neely J.R. Hearts from diabetic rats are more resistant to in vitro ischemia: Possible role of altered Ca2+ metabolism. Circ Res 62 (1988) 931
19. Kusama Y., Hearse D.J., and Avkiran M. Diabetes and susceptibility to reperfusion-induced ventricular arrhythmias. J Mol Cell Cardiol 24 (1992) 411
20. Blaisdell F.W. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: A review. Cardiovasc Surg 10 (2002) 620
21. Fischer E.G., Ames III A., Hedley-Whyte E.T., et al. Reassessment of cerebral capillary changes in acute global ischemia and their relationship to the "no-reflow phenomenon". Stroke 8 (1977) 36
22. Fischer E.G., Ames III A., and Lorenzo A.V. Cerebral blood flow immediately following brief circulatory stasis. Stroke 10 (1979) 423
23. Tamarat R., Silvestre J.S., Le Ricousse-Roussanne S., et al. Impairment in ischemia-induced neovascularization in diabetes: Bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol 164 (2004) 457
24. Stulc T., Kasalova Z., Prazny M., et al. Microvascular reactivity in patients with hypercholesterolemia: Effect of lipid lowering treatment. Physiol Res 52 (2003) 439
25. Taniyama Y., Morishita R., Hiraoka K., et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: Molecular mechanisms of delayed angiogenesis in diabetes. Circulation 104 (2001) 2344
26. Antoniades C., Tousoulis D., Tountas C., et al. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: The effects of vitamin C. Diabet Med 21 (2004) 552
27. Lu H., Raptis M., Black E., et al. Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue. Endocrinology 145 (2004) 4934
28. Qi X., Li J., Gu J., et al. Plasma levels of IL-8 predict early complications in patients with coronary heart disease after percutaneous coronary intervention. Jpn Heart J 44 (2003) 451
29. Nawas S.I., Doherty J.C., Vigneswaran W.T., et al. Cardiopulmonary bypass increases coronary IL-8 in diabetic patients without evidence of reperfusion injury. J Surg Res 84 (1999) 46
30. Belkin M., LaMorte W.L., Wright J.G., et al. The role of leukocytes in the pathophysiology of skeletal muscle ischemic injury. J Vasc Surg 10 (1989) 14 discussion 18
31. Heinrich P.C., Bode J., Decker M., et al. Termination and modulation of IL-6-type cytokine signaling. Adv Exp Med Biol 495 (2001) 153
32. Terstegen L., Maassen B.G., Radtke S., et al. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA. FEBS Lett 478 (2000) 100
33. Askari A., Unzek S., Goldman C.K., et al. Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy. J Am Coll Cardiol 43 (2004) 1908
34. Yau T.M., Li G., Weisel R.D., et al. Vascular endothelial growth factor transgene expression in cell-transplanted hearts. J Thorac Cardiovasc Surg 127 (2004) 1180
35. Ye L., Haider K.H., Jiang S.J., et al. Angiomyogenesis using human myoblast carrying human VEGF165 for injured heart. Ann Acad Med Singapore 32 (2003) S21
36. Chachques J.C., Cattadori B., Herreros J., et al. Treatment of heart failure with autologous skeletal myoblasts. Herz 27 (2002) 570
37. Jensen L., Bangsbo J., and Hellsten Y. Effect of high intensity training on capillarization and presence of angiogenic factors in human skeletal muscle. J Physiol 557 (2004) 571
38. Friehs I., Moran A.M., Stamm C., et al. Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury. Ann Thorac Surg 77 (2004) 2004 discussion 2011
39. Chou E., Suzuma I., Way K.J., et al. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: A possible explanation for impaired collateral formation in cardiac tissue. Circulation 105 (2002) 373
40. Wang P., and Chatham J.C. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am J Physiol Endocrinol Metab 286 (2004) E725
41. Schiekofer S., Galasso G., Sato K., et al. Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of a complex angiogenic-regulatory network. Arterioscler Thromb Vasc Biol 25 (2005) 1603
42. van Weel V., de Vries M., Voshol P.J., et al. Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice. Arterioscler Thromb Vasc Biol 26 (2006) 1383